Prevalence of irritable bowel syndrome and depression in fibromyalgia.

Digestive Diseases and Sciences
Jayde E KurlandElizabeth Zable

Abstract

The purpose of this study was to determine the point prevalence of depressive symptoms, using the PRIME-MD questionnaire, and irritable bowel syndrome (IBS), while comparing the Rome II to the Rome I criteria, in patients with fibromyalgia (FM) and rheumatologic controls in an outpatient setting. The prevalence of IBS in FM patients (n = 105) was 63% by Rome I and 81% by Rome II criteria. The prevalence of IBS in controls (n = 62) was 15% by Rome I and 24% by Rome II criteria (FM vs. control; P < 0.001). Depressive symptoms were met in 40% of FM patients and 8% of controls (P < 0.001). The coexistence of IBS and depressive symptoms in the FM patients was 31% (Rome I) and 34% (Rome II). The prevalence of IBS and depressive symptoms was higher in FM patients compared to the control population. Identification of IBS and depressive symptoms in FM patients might enable clinicians to better meet the needs of this patient population.

References

Jul 1, 1992·General Hospital Psychiatry·W Katon, H Schulberg
Jan 1, 1991·Digestive Diseases and Sciences·G TriadafilopoulosD L Goldenberg
Mar 1, 1994·Arthritis Care and Research : the Official Journal of the Arthritis Health Professions Association·C S BurckhardtR M Bennett
Jan 1, 1994·Psychotherapy and Psychosomatics·M ErcolaniR Marcolongo
Feb 23, 1999·The European Journal of Surgery. Supplement. : = Acta Chirurgica. Supplement·L Chang
Aug 24, 1999·Gut·W G ThompsonS A Müller-Lissner
Oct 16, 1999·The American Journal of Gastroenterology·S J VannerM Djurfeldt
Dec 22, 1999·The American Journal of Gastroenterology·A D SperberD Buskila
Jul 18, 2000·Scandinavian Journal of Rheumatology·M K SöderlinP Nieminen
Feb 1, 2003·European Journal of Gastroenterology & Hepatology·Fermín MearinNicholas J Talley
Jun 24, 2003·The American Journal of Gastroenterology·Lin ChangMark A Mandelkern
Oct 15, 2003·Arthritis and Rheumatism·Thorsten GieseckeDaniel J Clauw
Dec 23, 2003·The American Journal of Gastroenterology·Fermin MearinNicholas J Talley

❮ Previous
Next ❯

Citations

Jan 12, 2011·Rheumatology International·Esme Fuller-ThomsonSarah Brennenstuhl
Dec 13, 2006·Digestive Diseases and Sciences·Fuad Lechin, Bertha van der Dijs
Jun 8, 2012·The Clinical Journal of Pain·Philippe ChalayeSerge Marchand
Jan 1, 2009·Journal of Pain Research·Beth A ScholzChad S Boomershine
Dec 1, 2006·Neuropsychiatric Disease and Treatment·Chantal Moret, Mike Briley
May 31, 2014·World Journal of Gastroenterology : WJG·Constanze Hausteiner-Wiehle, Peter Henningsen
May 19, 2012·Scandinavian Journal of Gastroenterology·Arnold BerstadJørgen Valeur
Mar 7, 2008·Expert Opinion on Emerging Drugs·Jacob N Ablin, Dan Buskila
Jul 9, 2008·Current Medical Research and Opinion·Chi-Un PaeBoudewijn Van Houdenhove
Jul 23, 2013·Frontiers in Neuroendocrinology·Richard J Traub, Yaping Ji
May 14, 2011·Psychosomatics·Marina Díaz-MarsáJosé Luis Carrasco
Oct 15, 2011·European Journal of Pharmacology·Ronan DepoortèreAdrian Newman-Tancredi
Apr 13, 2011·The Journal of Pain : Official Journal of the American Pain Society·Paul G GreenJon D Levine
Jan 9, 2010·The American Journal of Medicine·Don L Goldenberg
Feb 17, 2009·Seminars in Arthritis and Rheumatism·Don L Goldenberg
Jan 14, 2009·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Cristina AlmansaManuel Díaz-Rubio
Oct 22, 2008·European Journal of Pain : EJP·Ritva MarkkulaJaakko Kaprio
Aug 18, 2010·Bipolar Disorders·William S WilkeDavid J Muzina
Sep 29, 2011·Pain Practice : the Official Journal of World Institute of Pain·Tom G MayerRobert J Gatchel
Mar 19, 2016·Pain Practice : the Official Journal of World Institute of Pain·Randy NeblettRobert J Gatchel
Aug 14, 2013·Neurogastroenterology and Motility : the Official Journal of the European Gastrointestinal Motility Society·B HoringP Enck
Oct 9, 2015·Clinical Reviews in Allergy & Immunology·Andrea T Borchers, M Eric Gershwin
Aug 15, 2014·Rheumatology International·Juan Miguel García-LeivaElena P Calandre
Dec 3, 2010·Journal of Occupational and Environmental Medicine·Krista J HowardRobert J Gatchel
Nov 6, 2014·The Clinical Journal of Pain·Dennis C AngTimothy Stump
Jan 1, 2021·Seminars in Arthritis and Rheumatism·Bethea A KleykampRobert H Dworkin
Dec 22, 2020·Therapeutic Advances in Gastroenterology·Sharon ErdrichJoanna E Harnett

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.